English
Chinese
English
España
Deutsch
Let us create a wonderful future together！
The liver, often referred to as the body's "silent hero," plays a vital role in various metabolic processes, detoxification, and hormone regulation. Maintaining optimal liver health is crucial for overall well-being, and early detection of liver disorders is essential for effective management. In the field of medical diagnostics, clinical diagnostic reagent assay kits have emerged as powerful tools for assessing liver function. These kits provide valuable insights into liver health by measuring specific biomarkers and enzymes present in blood samples.
Understanding Clinical Diagnostic Reagent Assay Kits:
Clinical diagnostic reagent assay kits are meticulously designed to detect and quantify biomarkers associated with liver function. These kits consist of reagents, calibrators, and controls that enable accurate measurement of enzymes, proteins, and other indicators of liver health. The assays utilize advanced techniques such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), or spectrophotometric methods to achieve precise and reliable results.
Key Biomarkers Measured:
Diagnostic reagent assay kits for liver function assess several key biomarkers that provide valuable information about liver health. These biomarkers include alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), bilirubin, albumin, and alkaline phosphatase (ALP). Abnormal levels of these biomarkers can indicate liver diseases, such as hepatitis, cirrhosis, or liver damage caused by alcohol, drugs, or other factors.
Role in Liver Disease Diagnosis and Monitoring:
Clinical diagnostic reagent assay kits have revolutionized the diagnosis and monitoring of liver diseases. By accurately measuring liver biomarkers, these kits assist healthcare professionals in detecting liver disorders at an early stage, monitoring disease progression, and evaluating treatment efficacy. They enable clinicians to make informed decisions regarding patient care, including the initiation of appropriate interventions and the adjustment of treatment plans.
【AFU】α-L-Fucosidase Assay Kit (Continuous Monitoring Method)
【AFU】α-L-Fucosidase Assay Kit (Continuous Monitoring Method)
Usage
This product is used to quantitatively detect the activity of α-L-fucosidase in human serum in vitro.
Background of Clinical Indications
It is used for the dynamic monitoring of hepatic cancer patients to assist in the diagnosis of disease progression or treatment effect. It can not be used as the basis for early diagnosis or confirmed diagnosis of malignant tumors, nor can it be used for tumor screening in general population. Its increase is common in patients with metastatic hepatic cancer and other diseases; it also has a slight increase in patients with hepatic cirrhosis, chronic hepatitis, and hemorrhage of digestive tract, etc.
